Phenotype-based targeted treatment of SGLT2 inhibitors and GLP-1 receptor agonists in type 2 diabetes

Data availability statement

The UK routine clinical data analysed during the current study are available in the CPRD repository (CPRD; https://cprd.com/research-applications), but restrictions apply to the availability of these data, which were used under license for the current study, and so are not publicly available. For re-using these data, an application must be made directly to CPRD. Data from Scotland are anonymized real-world medical records available by request through the Scottish Care Information-Diabetes Collaboration, Tayside & Fife, Scotland unit (https://www.sci-diabetes.scot.nhs.uk/). Clinical trial data are not publicly available, for access an application must be made directly to GSK and www.ClinicalStudyDataRequest.com